Profile:
Alexion Pharmaceuticals is a biopharmaceutical company focused on serving patients with severe and ultra-rare disorders through the innovation, development and commercialization of life-transforming products. Alexion developed and markets Soliris® (eculizumab) as a treatment for patients with PNH and aHUS. Alexion is evaluating other potential indications for Soliris and is developing four other innovative product candidates.

Categories

Biologicals

Pharmaceuticals